Vitamin K Injectable Syringes Recalled for Lack of Sterility Assurance
Sentara Infusion Services is recalling Vitamin K (Phytonadione) 2.5mg injectable syringes distributed nationwide due to lack of sterility assurance. Patients should contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (injectable medication with sterility concerns) where no illnesses or injuries have been reported in the source text. While FDA Class II, the lack of sterility assurance on an injectable drug presents a significant theoretical risk, meeting the High severity criterion for risk-of-harm products without reported injury.
Plain-English summary
Sentara Infusion Services is recalling Vitamin K (Phytonadione) 2.5mg (0.25mL) injectable syringes due to lack of sterility assurance. The affected product has a beyond-use date of December 29, 2022, and was dispensed to patients nationwide.
Sterility is critical for injectable products. A lack of sterility assurance means the product may not meet required safety standards for injectable administration.
Patients who received this product should contact their healthcare provider or pharmacist immediately. Healthcare providers should discontinue use of any affected syringes and contact Sentara Infusion Services for guidance on replacement or alternative treatments.
The recalled product
- Product
- VITAMIN K(PHYTONADIONE) 2.5MG(0.25ML) SYRINGE, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
- Manufacturer
- Sentara Infusion Services
- Category
- Drug — Injectable / Vitamin
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Beyond Use DateL December 29
- 2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27